Your browser doesn't support javascript.
loading
Identifying COVID-19 Vaccine Deserts and Ways to Reduce Them: A Digital Tool to Support Public Health Decision-Making.
Weintraub, Rebecca L; Miller, Kate; Rader, Benjamin; Rosenberg, Julie; Srinath, Shreyas; Woodbury, Samuel R; Schultheiss, Marinanicole D; Kansal, Mansi; Vispute, Swapnil; Serghiou, Stylianos; Flores, Gerardo; Kumok, Akim; Shekel, Tomer; Gabrilovich, Evgeniy; Ahmad, Iman; Chiang, Molly E; Brownstein, John S.
Afiliação
  • Weintraub RL; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Miller K; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Rader B; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Rosenberg J; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Srinath S; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Woodbury SR; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Schultheiss MD; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Kansal M; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Vispute S; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Serghiou S; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Flores G; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Kumok A; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Shekel T; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Gabrilovich E; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Ahmad I; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Chiang ME; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
  • Brownstein JS; At the time of this work, Rebecca L. Weintraub, Kate Miller, Julie Rosenberg, Shreyas Srinath, Samuel R. Woodbury, and Iman Ahmad were with Ariadne Labs, Boston, MA. Benjamin Rader, Marinanicole D. Schultheiss, Molly E. Chiang, and John S. Brownstein were with Computational Epidemiology Lab, Boston
Am J Public Health ; 113(4): 363-367, 2023 04.
Article em En | MEDLINE | ID: mdl-36730873

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Public Health Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Am J Public Health Ano de publicação: 2023 Tipo de documento: Article